PT Kimia Farma Tbk (PT Kimia Farma Tbk) ROCE % : -72.94% (As of Dec. 2023)

View and export this data going back to 2015. Start your Free Trial

What is PT Kimia Farma Tbk ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. PT Kimia Farma Tbk's annualized ROCE % for the quarter that ended in Dec. 2023 was -72.94%.

PT Kimia Farma Tbk ROCE % Historical Data

The historical data trend for PT Kimia Farma Tbk's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Kimia Farma Tbk ROCE % Chart

PT Kimia Farma Tbk Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

6.21

6.12

9.30

4.47

-16.21

PT Kimia Farma Tbk Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															12.58	4.56	3.96	0.23	-72.94

PT Kimia Farma Tbk ROCE % Calculation

PT Kimia Farma Tbk's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-100.207	/	( ( (1258.491 - 552.493)	+	(1140.717 - 610.388) )	/ 2 )
	=	-100.207	/	( (705.998	+	530.329)	/ 2 )
	=	-100.207	/	618.1635
	=	-16.21 %

PT Kimia Farma Tbk's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	-468.484	/	( ( (1323.63 - 569.318)	+	(1140.717 - 610.388) )	/ 2 )
	=	-468.484	/	( ( 754.312	+	530.329 )	/ 2 )
	=	-468.484	/	642.3205
	=	-72.94 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

PT Kimia Farma Tbk (GREY:PTKMF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

PT Kimia Farma Tbk ROCE % Related Terms

Thank you for viewing the detailed overview of PT Kimia Farma Tbk's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Kimia Farma Tbk (PT Kimia Farma Tbk) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » PT Kimia Farma Tbk (GREY:PTKMF) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

KAEF:Indonesia

Address

Jalan Veteran No. 9 Gambir, Jakarta Pusat, Jakarta, IDN, 10110

Website

https://www.kimiafarma.co.id

PT Kimia Farma Tbk is an Indonesia based company engaged in the production and distribution of healthcare products. It operates through the following segments: Manufacture, Distribution, Retail, and Others. The company provides its products in three categories including Ethical, Generic and others. Some of its product offerings include Topgesic, Protofen, Neurodial, Omeprazole, Antalgin, Pethidine, Salicylfresh and Doveri. It generates maximum revenue from the retail segment.

PT Kimia Farma Tbk (PT Kimia Farma Tbk) Headlines

No Headlines